Catalyst Wire Dossier Catalyst Wire Dossier

Belimumab (Benlysta)

belimumab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Belimumab (Benlysta), covering 2013-08-02 to 2013-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 1]

See pricing